APVO - Aptevo Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

APVO is currently covered by 1 analysts with an average price target of $62583.57. This is a potential upside of $62580.32 (1925548.31%) from yesterday's end of day stock price of $3.25.

Aptevo Therapeutics's activity chart (see below) currently has 7 price targets and 19 ratings on display. The stock rating distribution of APVO is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for APVO is $7, Lowest price target is $7.

Most recent stock forecast was given by JONATHAN ASCHOFF from ROTH on 23-Sep-2024. First documented stock forecast 05-Oct-2017.

Best performing analysts who are covering APVO - Aptevo Therapeutics:

Edward Tenthoff Jonathan Aschoff

Currently out of the existing stock ratings of APVO, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

9 months ago
(23-Sep-2024)

0/2 (0%)

$38876.64 (91.42%)

Buy

2 years 10 months 11 days ago
(12-Aug-2022)

0/3 (0%)

$86284 (331.25%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is APVO (Aptevo Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on APVO (Aptevo Therapeutics) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on APVO (Aptevo Therapeutics) with a proven track record?

JONATHAN ASCHOFF

Which analyst has the most public recommendations on APVO (Aptevo Therapeutics)?

Edward Tenthoff works at PIPER SANDLER and has 5 price targets and 4 ratings on APVO

Which analyst is the currently most bullish on APVO (Aptevo Therapeutics)?

Jonathan Aschoff with highest potential upside - $0

Which analyst is the currently most reserved on APVO (Aptevo Therapeutics)?

Edward Tenthoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?